Procymate

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 06:26, 23 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Procymate
Clinical data
Routes of
administration		oral
ATC code
  • none
Identifiers
  • carbamic acid 1-cyclohexylpropyl ester
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H19O2
Molar mass171.260 g·mol−1
3D model (JSmol)
  • CCC(C1CCCCC1)OC(=O)N
  • InChI=1S/C10H19NO2/c1-2-9(13-10(11)12)8-6-4-3-5-7-8/h8-9H,2-7H2,1H3,(H2,11,12) ☒N
  • Key:IGISNRIWPJVXDB-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Procymate (Equipax) is a carbamate derivative which is a sedative and anxiolytic drug. It was previously manufactured and marketed in Belgium. The usual dose for adults is 800 to 1200 mg per day.[1] Procymate shares a similar structure and mechanism of action with the related drugs hexapropymate and phenprobamate.

References

  1. ^ "Procymate," Bank of Automated Data on Drugs. VIDAL Drug Database. <http://www.biam2.org/www/Sub394.html>


Stub icon

This sedative-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Procymate&oldid=964034320"